The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation is a research paper published in Breast Cancer Research and Treatment (2022). On theSindex it has a DataRank of 0.749. It has been cited 23 times, with 15 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.477
From this paper's citation signal
Citation Network Contribution
0.272
From 13 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 15 citers.
National Cancer Institute
Grant: 5RO1 CA200795
National Cancer Institute
Grant: P30 CA008748
NCATS NIH HHS
Grant: UL1 TR002384
NCI NIH HHS
Grant: R01 CA200795
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA200795-02
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.
FWCI
1.94
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Additional file 1 of Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Additional file 2 of Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Additional file 2 of Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Additional file 3 of Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Additional file 3 of Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Additional file 4 of Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Additional file 4 of Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women